Folic acid, vitamin B12, and homocysteine levels during fasting and after methionine load in patients with type 1 diabetes mellitus

Journal of Endocrinological Investigation

Volumn 33, Issue 5, 2010, Pages 297-299

  Giannattasio, A ^a   Calevo, M G ^b   Minniti, G ^a   Gianotti, D ^c   Cotellessa, M ^a   Napoli, F ^a   Lorini, R ^a   D'Annunzio, G ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b G GASLINI INSTITUTE   (Italy)

^c UNIVERSITY OF PARMA   (Italy)

Author keywords

Folic acid; Homocysteine; Microangiopathy; Type 1 diabetes mellitus; Vitamin B12

Indexed keywords

CYANOCOBALAMIN; FOLIC ACID; GLYCOSYLATED HEMOGLOBIN; HOMOCYSTEINE; INSULIN; METHIONINE;

ADOLESCENT; ADULT; AGE; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; DISEASE DURATION; FEMALE; FOLIC ACID BLOOD LEVEL; HUMAN; HYPERHOMOCYSTEINEMIA; INSULIN DEPENDENT DIABETES MELLITUS; MALE; METABOLIC REGULATION; SCHOOL CHILD;

ADOLESCENT; ADULT; AGING; BLOOD GLUCOSE; CASE-CONTROL STUDIES; CHILD; DIABETES MELLITUS, TYPE 1; FASTING; FEMALE; FOLIC ACID; HOMOCYSTEINE; HUMANS; MALE; METHIONINE; SEX CHARACTERISTICS; VITAMIN B 12; YOUNG ADULT;

EID: 77954201435     PISSN: 03914097     EISSN: 17208386     Source Type: Journal    
DOI: 10.3275/6565     Document Type: Article

References (23)

1. Selhub J. Homocysteine metabolism. Annu Rev Nutr 1999,19:217-46.
2. Graham IM, Daly LE, Refsum HM, et al. Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project. JAMA 1997, 277:1775-81.
3. Selhub J. Public health significance of elevated homocysteine. Food Nutr Bull 2008, 29 (Suppl 2): S116-25,
4. Morrish NJ, Wang SL, Stevens LK, Fuller JH, Keen H. Mortality and causes of death in the WHO Multinational Study of Vascular Disease in Diabetes. Diabetologia 2001,44 (Suppl 2): S14-21. (Pubitemid 32844108)
5. Hofmann MA Kohl B, Zumbach MS, et al. Hyperhomocyst(e)inemia and endothelial dysfunction in IDDM. Diabetes Care 1997, 20: 1880-6.
6. Cronin CC, McPartlin JM, Barry DG, Ferriss JB, Scott JM, Weir DG. Plasma homocysteine concentrations in patients with type 1 diabetes. Diabetes Care 1998,21:1843-7.
7. Pavía C, Ferrer I, VaIIs C, Artuch R, Colomé C, Vilaseca MA. Total homocysteine in patients with type 1 diabetes. Diabetes Care 2000, 23: 84-7. (Pubitemid 30022900)
8. Wiltshire E, Thomas DW, Baghurst P, Couper J. Reduced total plasma homocysteine in children and adolescents with type 1 diabetes. J Pediatr 2001,138:888-93. (Pubitemid 32545592)
9. Salardi S, Cacciari E, Sassi S, et al. Homocysteinemia, serum folate and vitamin B12 in very young patients with diabetes mellitus type 1. J Pediatr Endocrinol Metab 2000,13:1621-7.
10. Cotellessa M, Minniti G, Cerone R, Prigione F, Calevo MG, Lorini R. Low total plasma homocysteine concentrations in patients with type 1 diabetes. Diabetes Care 2001,24: 969-71.
11. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997, 20 (Suppl 1): 1183-97.
12. Minniti G, Cerone R, Piana A, Armani U, Lorini R. Plasma and serum total homocysteine concentrations in paediatric patients, evaluated by high-performance liquid chromatography with fluorescence. Clin Chem Ub Med 2000, 38: 675-6.
13. Hoey L, McNulty H, Askin N, et al. Effect of a voluntary food forti fication policy on folate, related B vitamin status, and homocysteine in healthy adults. Am J Clin Nutr 2007,86:1405-13.
14. Jacques PF, Selhub J, Bostom AG, Wilson PW, Rosenberg IH. The effect of folic acid fortification on plasma folate and total homocysteine concentrations. N Engl J Med 1999, 340: 1449-54. (Pubitemid 29220543)
15. Chiarelli F, Pomilio M, Mohn A et al. Homocysteine levels during fasting and after methionine loading in adolescents with diabetic retinopathy and nephropathy. J Pediatr 2000, 137: 386-92.
16. Veldman BA, Vervoort G, Blom H, Smits P. Reduced plasma total homocysteine concentrations in Type 1 diabetes mellitus is determined by increased renal clearance. Diabet Med 2005,22:301-5. (Pubitemid 40313857)
17. Matteucci E, Rossi L, Mariani S et al. Blood levels of total homocysteine in patients with type 1 diabetes (with no complications, diabetic nephropathy and/or retinopathy) and in their non-diabetic relatives. Nutr Metab Cardiovasc Dis 2002,12:184-9.
18. Wollesen F, Brattström L, Refsum H, Ueland PM, Berglund L, Berne C. Plasma total homocysteine and cysteine in relation to glomerular filtration rate in diabetes mellitus. Kidney lnt 1999, 55: 1028-35.
19. Smulders YM, Rakic M, Slaats EH, et al. Fasting and post-methionine homocysteine levels in NIDDM. Determinants and correlations with retinopathy, albuminuria, and cardiovascular disease. Diabetes Care 1999,22:125-32.
20. Wotherspoon F, Laight DW, Browne DL, et al. Plasma homocysteine, oxidative stress and endothelial function in patients with Type 1 diabetes mellitus and microalbuminuria. Diabet Med 2006, 23:135CW. (Pubitemid 44787800)
21. Cerone R, Minniti G, Piana A, Armani U, Lorini R. Mild hyperhomocysteinemia: vitamin supplementation or not? Am J Clin Nutr 2001,74:271-2.
22. Boushey CJ, Beresford SA, Omenn GS, Motulsky AG. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA 1995, 274: 1049-57.
23. Wotherspoon F, Laight DW, Turner C, et al. The effect of oral folic acid upon plasma homocysteine, endothelial function and oxidative stress in patients with type 1 diabetes and microalbuminuria. Int J Clin Pract 2008, 62: 569-74.